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Background
GAIA Vaccine Foundation (GAIA VF) has been working
alongside the Department of Health (DRS), HIV expert
clinicians, and basic scientists in Mali to prepare a site
for Phase I-III HIV vaccine trials. The proposed location
for the Phase I-III trials to be conducted in this colla-
boration is Sikoro, a multi-ethnic village with a popula-
tion of over 40,000 located near Bamako, Mali.
Methods
To date, GAIA VF, the DRS, and Malian clinicians and
scientists have collaborated on: (1) HIV education in
Sikoro and Bamako, (2) HIV prevention in Sikoro, (3)
access to HIV treatment in Sikoro, and (4) vaccine readi-
ness studies in Bamako and Sikoro. Regular meetings and
extensive collaborations have been established among
GAIA VF, regional scientists, and government officials.
Results
An HIV transmission prevention (MTCTP) program was
established in the Sikoro prenatal care clinic (Chez Rosa-
lie) in 2005; the Hope HIV Care Center (Bloc Espoir) was
completed in 2008, and GAIA VF established the first ‘pri-
mary-care-setting’ HIV treatment program in Mali in
2009. >10,000 pregnant women have been screened for
HIV infection, >200 have been diagnosed with HIV; conti-
nuing access to HIV treatment and nutritional support
was made available for these women and their spouses
and children in Bloc Espoir. Peer educators distributed
>47,000 condoms and provided peer-to-peer education to
>22,000 individuals over 5 years. >300 ‘walk-in’ patients
have been screened for treatment at the on-site care cen-
ter, and >195 individuals are currently receiving antiretro-
viral therapy in this low resource setting.
Conclusion
GAIA VF has established successful local and regional
partnerships in Mali, performed vaccine readiness
research, and implemented a comprehensive HIV care
program in anticipation of performing HIV vaccine
trials. A Phase IV HPV vaccine trial in Mali is antici-
pated in 2012, which will build local expertise and capa-
city for future HIV vaccine trials.
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